<div class="subbannerpanel module">
    <div class="grid-container-fullwidth">
        <div class="bannerwrap">
            <div class="imgWrap">
                <picture>
                    <source media="(min-width:320px) and (max-width:430px)"
                        srcset="{{root}}assets/images/mobile-banner.jpg" type="image/jpg">
                    <source media="(min-width: 431px)" srcset="{{root}}assets/images/banner.jpg" type="image/jpg">
                    <img src="{{root}}assets/images/banner.jpg" alt="The people banner" width="1920" height="563">
                </picture>
            </div>
            <div class="grid-container">
                <div class="contentwrap">
                    <div class="content">
                        <h1>Let's Talk Laterally</h1>
                        <p>Explore how our creative approach sheds new light on your future success</p>
                    </div>
                </div>
            </div>
        </div>
    </div>
</div>




<div class="experiencePanel mb110 module">
    <div class="grid-container">
        <div class="wraps">
            <h2>Experience</h2>
        </div>
        <p>We represent clients across a wide range of industries. Please click on any of the practice links below
            to<br>
            see a representative list of matters and clients.</p>
    </div>
    <div class="accordionSec">
        <div class="grid-container">

            <div class="tabHorizontal">
                <div class="custom-dropdown" style="display: none;">
                    <button class="dropdown-toggle tabmob">Private Equity / M&A</button>

                    <ul class="dropdown-menu" style="display: none;">
                        <li data-tab="tab-1">Private Equity / M&A</li>
                        <li data-tab="tab-2" class="active">Investment Management
                            Funds</li>
                        <li class="" data-tab="tab-3">Capital Markets</li>
                        <li class="" data-tab="tab-4">Life Sciences</li>
                        <li class="" data-tab="tab-5">Bankruptcy</li>
                        <li class="" data-tab="tab-6">Litigation</li>
                        <li class="" data-tab="tab-7">Emerging Companies &
                            Venture Capital</li>
                        <li class="" data-tab="tab-8">Intellectual Property</li>
                        <li class="" data-tab="tab-9">Artificial Intelligence</li>
                        <li class="" data-tab="tab-10">Crypto</li>
                    </ul>
                </div>
                <ul class="tab-links" style="">
                    <li class="active" data-tab="tab-1">Private Equity / M&A</li>
                    <li class="" data-tab="tab-2">Investment Management
                        Funds</li>
                    <li class="" data-tab="tab-3">Capital Markets</li>
                    <li class="" data-tab="tab-4">Life Sciences</li>
                    <li class="" data-tab="tab-5">Bankruptcy</li>
                    <li class="" data-tab="tab-6">Litigation</li>
                    <li class="" data-tab="tab-7">Emerging Companies &
                        Venture Capital</li>
                    <li class="" data-tab="tab-8">Intellectual Property</li>
                    <li class="" data-tab="tab-9">Artificial Intelligence</li>
                    <li class="" data-tab="tab-10">Crypto</li>
                </ul>
                <div class="tab-content">
                    <div id="tab-1" class="tab-pane active">
                        <div class="flexwrap">

                            <div class="card">
                                <div class="insideCard">
                                    <div class="front">
                                        <img src="{{root}}assets/images/experience/Coya.png" alt="Coya" class="lazy">
                                        <img src="{{root}}assets/images/experience/Dr-Reddys.png" alt="Dr Reddys"
                                            class="lazy">
                                        <div class="readMore">
                                            <i></i>
                                        </div>
                                    </div>
                                    <div class="back">
                                        <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license
                                            deal with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                    </div>
                                </div>

                            </div>
                            <div class="card">
                                <div class="insideCard">
                                    <div class="front">
                                        <img src="{{root}}assets/images/experience/Hildred.png" alt="Hildred"
                                            class="lazy">
                                        <img src="{{root}}assets/images/experience/Hylands-Naturals.png"
                                            alt="Hylands-Naturals" class="lazy">
                                        <img src="{{root}}assets/images/experience/Crown-Laboratories.png"
                                            alt="Crown-Laboratories" class="lazy">
                                        <div class="readMore">
                                            <i></i>
                                        </div>
                                    </div>
                                    <div class="back">
                                        <p>March 2024</p>
                                        <h3>$750,000,000​</h3>
                                        <p>Represented Hildred Capital Management in raising capital for its
                                            continuation
                                            fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                        </p>
                                    </div>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Bigeye.png" alt="Bigeye" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Burford.png" alt="Burford" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Coach-USA.png" alt="Coach-USA"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Context-Therapeutics.png"
                                        alt="Context-Therapeutics" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Delphia.png" alt="Delphia" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Dr.Scholls.png" alt="Dr Scholls"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Galaxy.png" alt="Galaxy" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/GNC.png" alt="GNC" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Hertz.png" alt="Hertz" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Luxium.png" alt="Luxium" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Marathon-Asset-Management.png"
                                        alt="Marathon-Asset-Management" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Nomi-Health.png" alt="Nomi-Health"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Pineapple.png" alt="Pineapple"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/rue21.png" alt="rue 21" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>


                        </div>
                    </div>
                    <div id="tab-2" class="tab-pane">
                        <div class="flexwrap">

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Coya.png" alt="Coya" class="lazy">
                                    <img src="{{root}}assets/images/experience/Dr-Reddys.png" alt="Dr Reddys"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Hildred.png" alt="Hildred" class="lazy">
                                    <img src="{{root}}assets/images/experience/Hylands-Naturals.png"
                                        alt="Hylands-Naturals" class="lazy">
                                    <img src="{{root}}assets/images/experience/Crown-Laboratories.png"
                                        alt="Crown-Laboratories" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Bigeye.png" alt="Bigeye" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Burford.png" alt="Burford" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Coach-USA.png" alt="Coach-USA"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Context-Therapeutics.png"
                                        alt="Context-Therapeutics" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Delphia.png" alt="Delphia" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Dr.Scholls.png" alt="Dr Scholls"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Galaxy.png" alt="Galaxy" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/GNC.png" alt="GNC" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Hertz.png" alt="Hertz" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Luxium.png" alt="Luxium" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Marathon-Asset-Management.png"
                                        alt="Marathon-Asset-Management" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Nomi-Health.png" alt="Nomi-Health"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Pineapple.png" alt="Pineapple"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/rue21.png" alt="rue 21" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>


                        </div>
                    </div>
                    <div id="tab-3" class="tab-pane">
                        <div class="flexwrap">

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Coya.png" alt="Coya" class="lazy">
                                    <img src="{{root}}assets/images/experience/Dr-Reddys.png" alt="Dr Reddys"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Hildred.png" alt="Hildred" class="lazy">
                                    <img src="{{root}}assets/images/experience/Hylands-Naturals.png"
                                        alt="Hylands-Naturals" class="lazy">
                                    <img src="{{root}}assets/images/experience/Crown-Laboratories.png"
                                        alt="Crown-Laboratories" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Bigeye.png" alt="Bigeye" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Burford.png" alt="Burford" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Coach-USA.png" alt="Coach-USA"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Context-Therapeutics.png"
                                        alt="Context-Therapeutics" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Delphia.png" alt="Delphia" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Dr.Scholls.png" alt="Dr Scholls"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Galaxy.png" alt="Galaxy" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/GNC.png" alt="GNC" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Hertz.png" alt="Hertz" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Luxium.png" alt="Luxium" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Marathon-Asset-Management.png"
                                        alt="Marathon-Asset-Management" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Nomi-Health.png" alt="Nomi-Health"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Pineapple.png" alt="Pineapple"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/rue21.png" alt="rue 21" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>


                        </div>
                    </div>
                    <div id="tab-4" class="tab-pane">
                        <div class="flexwrap">

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Coya.png" alt="Coya" class="lazy">
                                    <img src="{{root}}assets/images/experience/Dr-Reddys.png" alt="Dr Reddys"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Hildred.png" alt="Hildred" class="lazy">
                                    <img src="{{root}}assets/images/experience/Hylands-Naturals.png"
                                        alt="Hylands-Naturals" class="lazy">
                                    <img src="{{root}}assets/images/experience/Crown-Laboratories.png"
                                        alt="Crown-Laboratories" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Bigeye.png" alt="Bigeye" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Burford.png" alt="Burford" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Coach-USA.png" alt="Coach-USA"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Context-Therapeutics.png"
                                        alt="Context-Therapeutics" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Delphia.png" alt="Delphia" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Dr.Scholls.png" alt="Dr Scholls"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Galaxy.png" alt="Galaxy" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/GNC.png" alt="GNC" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Hertz.png" alt="Hertz" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Luxium.png" alt="Luxium" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Marathon-Asset-Management.png"
                                        alt="Marathon-Asset-Management" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Nomi-Health.png" alt="Nomi-Health"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Pineapple.png" alt="Pineapple"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/rue21.png" alt="rue 21" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>


                        </div>
                    </div>
                    <div id="tab-5" class="tab-pane">
                        <div class="flexwrap">

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Coya.png" alt="Coya" class="lazy">
                                    <img src="{{root}}assets/images/experience/Dr-Reddys.png" alt="Dr Reddys"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Hildred.png" alt="Hildred" class="lazy">
                                    <img src="{{root}}assets/images/experience/Hylands-Naturals.png"
                                        alt="Hylands-Naturals" class="lazy">
                                    <img src="{{root}}assets/images/experience/Crown-Laboratories.png"
                                        alt="Crown-Laboratories" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Bigeye.png" alt="Bigeye" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Burford.png" alt="Burford" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Coach-USA.png" alt="Coach-USA"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Context-Therapeutics.png"
                                        alt="Context-Therapeutics" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Delphia.png" alt="Delphia" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Dr.Scholls.png" alt="Dr Scholls"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Galaxy.png" alt="Galaxy" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/GNC.png" alt="GNC" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Hertz.png" alt="Hertz" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Luxium.png" alt="Luxium" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Marathon-Asset-Management.png"
                                        alt="Marathon-Asset-Management" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Nomi-Health.png" alt="Nomi-Health"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Pineapple.png" alt="Pineapple"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/rue21.png" alt="rue 21" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>


                        </div>
                    </div>
                    <div id="tab-6" class="tab-pane">
                        <div class="flexwrap">

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Coya.png" alt="Coya" class="lazy">
                                    <img src="{{root}}assets/images/experience/Dr-Reddys.png" alt="Dr Reddys"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Hildred.png" alt="Hildred" class="lazy">
                                    <img src="{{root}}assets/images/experience/Hylands-Naturals.png"
                                        alt="Hylands-Naturals" class="lazy">
                                    <img src="{{root}}assets/images/experience/Crown-Laboratories.png"
                                        alt="Crown-Laboratories" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Bigeye.png" alt="Bigeye" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Burford.png" alt="Burford" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Coach-USA.png" alt="Coach-USA"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Context-Therapeutics.png"
                                        alt="Context-Therapeutics" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Delphia.png" alt="Delphia" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Dr.Scholls.png" alt="Dr Scholls"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Galaxy.png" alt="Galaxy" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/GNC.png" alt="GNC" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Hertz.png" alt="Hertz" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Luxium.png" alt="Luxium" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Marathon-Asset-Management.png"
                                        alt="Marathon-Asset-Management" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Nomi-Health.png" alt="Nomi-Health"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Pineapple.png" alt="Pineapple"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/rue21.png" alt="rue 21" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>


                        </div>
                    </div>
                    <div id="tab-7" class="tab-pane">
                        <div class="flexwrap">

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Coya.png" alt="Coya" class="lazy">
                                    <img src="{{root}}assets/images/experience/Dr-Reddys.png" alt="Dr Reddys"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Hildred.png" alt="Hildred" class="lazy">
                                    <img src="{{root}}assets/images/experience/Hylands-Naturals.png"
                                        alt="Hylands-Naturals" class="lazy">
                                    <img src="{{root}}assets/images/experience/Crown-Laboratories.png"
                                        alt="Crown-Laboratories" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Bigeye.png" alt="Bigeye" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Burford.png" alt="Burford" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Coach-USA.png" alt="Coach-USA"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Context-Therapeutics.png"
                                        alt="Context-Therapeutics" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Delphia.png" alt="Delphia" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Dr.Scholls.png" alt="Dr Scholls"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Galaxy.png" alt="Galaxy" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/GNC.png" alt="GNC" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Hertz.png" alt="Hertz" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Luxium.png" alt="Luxium" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Marathon-Asset-Management.png"
                                        alt="Marathon-Asset-Management" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Nomi-Health.png" alt="Nomi-Health"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Pineapple.png" alt="Pineapple"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/rue21.png" alt="rue 21" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>


                        </div>
                    </div>
                    <div id="tab-8" class="tab-pane">
                        <div class="flexwrap">

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Coya.png" alt="Coya" class="lazy">
                                    <img src="{{root}}assets/images/experience/Dr-Reddys.png" alt="Dr Reddys"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Hildred.png" alt="Hildred" class="lazy">
                                    <img src="{{root}}assets/images/experience/Hylands-Naturals.png"
                                        alt="Hylands-Naturals" class="lazy">
                                    <img src="{{root}}assets/images/experience/Crown-Laboratories.png"
                                        alt="Crown-Laboratories" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Bigeye.png" alt="Bigeye" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Burford.png" alt="Burford" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Coach-USA.png" alt="Coach-USA"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Context-Therapeutics.png"
                                        alt="Context-Therapeutics" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Delphia.png" alt="Delphia" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Dr.Scholls.png" alt="Dr Scholls"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Galaxy.png" alt="Galaxy" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/GNC.png" alt="GNC" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Hertz.png" alt="Hertz" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Luxium.png" alt="Luxium" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Marathon-Asset-Management.png"
                                        alt="Marathon-Asset-Management" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Nomi-Health.png" alt="Nomi-Health"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Pineapple.png" alt="Pineapple"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/rue21.png" alt="rue 21" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>


                        </div>
                    </div>
                    <div id="tab-9" class="tab-pane">
                        <div class="flexwrap">

                            <div class="card">
                                <div class="insideCard">
                                    <div class="front">
                                        <img src="{{root}}assets/images/experience/Coya.png" alt="Coya" class="lazy">
                                        <img src="{{root}}assets/images/experience/Dr-Reddys.png" alt="Dr Reddys"
                                            class="lazy">
                                        <div class="readMore">
                                            <i></i>
                                        </div>
                                    </div>
                                    <div class="back">
                                        <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license
                                            deal with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                    </div>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Hildred.png" alt="Hildred" class="lazy">
                                    <img src="{{root}}assets/images/experience/Hylands-Naturals.png"
                                        alt="Hylands-Naturals" class="lazy">
                                    <img src="{{root}}assets/images/experience/Crown-Laboratories.png"
                                        alt="Crown-Laboratories" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Bigeye.png" alt="Bigeye" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Burford.png" alt="Burford" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Coach-USA.png" alt="Coach-USA"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Context-Therapeutics.png"
                                        alt="Context-Therapeutics" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Delphia.png" alt="Delphia" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Dr.Scholls.png" alt="Dr Scholls"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Galaxy.png" alt="Galaxy" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/GNC.png" alt="GNC" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Hertz.png" alt="Hertz" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Luxium.png" alt="Luxium" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Marathon-Asset-Management.png"
                                        alt="Marathon-Asset-Management" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Nomi-Health.png" alt="Nomi-Health"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Pineapple.png" alt="Pineapple"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/rue21.png" alt="rue 21" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>


                        </div>
                    </div>
                    <div id="tab-10" class="tab-pane">
                        <div class="flexwrap">

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Coya.png" alt="Coya" class="lazy">
                                    <img src="{{root}}assets/images/experience/Dr-Reddys.png" alt="Dr Reddys"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Hildred.png" alt="Hildred" class="lazy">
                                    <img src="{{root}}assets/images/experience/Hylands-Naturals.png"
                                        alt="Hylands-Naturals" class="lazy">
                                    <img src="{{root}}assets/images/experience/Crown-Laboratories.png"
                                        alt="Crown-Laboratories" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Bigeye.png" alt="Bigeye" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Burford.png" alt="Burford" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Coach-USA.png" alt="Coach-USA"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Context-Therapeutics.png"
                                        alt="Context-Therapeutics" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Delphia.png" alt="Delphia" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Dr.Scholls.png" alt="Dr Scholls"
                                        class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Galaxy.png" alt="Galaxy" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/GNC.png" alt="GNC" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$750,000,000​</h3>
                                    <p>Represented Hildred Capital Management in raising capital for its continuation
                                        fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                    </p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Hertz.png" alt="Hertz" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>March 2024</p>
                                    <h3>$26,500,000​</h3>
                                    <p><strong>Private Placement</strong></p>
                                    <p>Represented NASDAQ: COYA​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Luxium.png" alt="Luxium" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>February 2024</p>
                                    <h3>$94,500,000​</h3>
                                    <p><strong>Underwritten Public Offering </strong></p>
                                    <p>Represented NASDAQ: CRBP​</p>
                                    <p>Issuer</p>
                                </div>
                            </div>

                            <div class="card">
                                <div class="front">
                                    <img src="{{root}}assets/images/experience/Marathon-Asset-Management.png"
                                        alt="Marathon-Asset-Management" class="lazy">
                                    <div class="readMore">
                                        <i></i>
                                    </div>
                                </div>
                                <div class="back">
                                    <p>Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal
                                        with Dr. Reddy’s Laboratories for its COYA 302 drug</p>
                                </div>
                            </div>
                            <div class="card">
                                <div class="insideCard">
                                    <div class="front">
                                        <img src="{{root}}assets/images/experience/Nomi-Health.png" alt="Nomi-Health"
                                            class="lazy">
                                        <div class="readMore">
                                            <i></i>
                                        </div>
                                    </div>
                                    <div class="back">
                                        <p>March 2024</p>
                                        <h3>$750,000,000​</h3>
                                        <p>Represented Hildred Capital Management in raising capital for its
                                            continuation
                                            fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
                                        </p>
                                    </div>
                                </div>
                            </div>
                            <div class="card">
                                <div class="insideCard">
                                    <div class="front">
                                        <img src="{{root}}assets/images/experience/Pineapple.png" alt="Pineapple"
                                            class="lazy">
                                        <div class="readMore">
                                            <i></i>
                                        </div>
                                    </div>
                                </div>
                            </div>
                            <div class="card">
                                <div class="insideCard">
                                    <div class="front">
                                        <img src="{{root}}assets/images/experience/rue21.png" alt="rue 21" class="lazy">
                                        <div class="readMore">
                                            <i></i>
                                        </div>
                                    </div>
                                </div>
                            </div>


                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>
</div>

<script type="text/javascript" defer="">
    $(document).ready(function () {
        function handleTabClick() {
            var tabId = $(this).data('tab');
            $('.tab-links li').removeClass('active');
            $('.tab-pane').removeClass('active');
            $(this).addClass('active');
            $('#' + tabId).addClass('active');
            $('.dropdown-toggle.tabmob').text($(this).text());
        }
        function handleDropdownToggle() {
            $('.dropdown-menu').toggle();
        }
        function handleDropdownItemClick() {
            var tabId = $(this).data('tab');
            $('.tab-links li').removeClass('active');
            $('.dropdown-menu li').removeClass('active');
            $('.tab-pane').removeClass('active');
            $('.tab-links li[data-tab="' + tabId + '"]').addClass('active');
            $('.dropdown-menu li[data-tab="' + tabId + '"]').addClass('active');
            $('#' + tabId).addClass('active');
            $('.dropdown-toggle.tabmob').text($(this).text());
            $('.dropdown-menu').hide();
        }
        $('.tab-links li').on('click', handleTabClick);
        $('.dropdown-toggle.tabmob').on('click', handleDropdownToggle);
        $('.dropdown-menu li').on('click', handleDropdownItemClick);
        $(document).on('click', function (event) {
            if (!$(event.target).closest('.custom-dropdown').length) {
                $('.dropdown-menu').hide();
            }
        });
        function adjustLayout() {
            if ($(window).width() <= 1023) {
                $('.tab-links').hide();
                $('.custom-dropdown').show();
            } else {
                $('.tab-links').show();
                $('.custom-dropdown').hide();
            }
        }
        $(window).on('resize', adjustLayout);
        adjustLayout();

        $('.card').each(function () {
            let $card = $(this);
            console.log($card.children());
            $card.hover(
                function (e) {
                    e.preventDefault();
                    // Store the timeout ID
                    if ($card.find('.back').length === 0) {
                        return; // Exit if .back is not present
                    }

                    let timeoutId = setTimeout(function () {
                        $card.find('.insideCard').css('transform', 'rotateY(180deg)');
                    }, 1000); // Flip after 1 second
                    $card.data('timeoutId', timeoutId);
                },
                function (e) {
                    e.preventDefault();
                    // Clear the timeout to avoid delayed execution
                    clearTimeout($card.data('timeoutId'));
                    $card.find('.insideCard').css('transform', 'rotateY(0deg)');
                }
            );
        });
    });



    // $(window).on('resize', function () {
    //     var setHeight = $('.card').outerWidth();
    //     $('.card').css('height', setHeight + 'px');
    // });
</script>